Cargando…
Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group
INTRODUCTION: Although a growing selection of antidepressants is available, a significant number of patients do not reach clinical remission, despite multiple trials. Data concerning the efficacy and safety of combination therapies with newer antidepressants are limited. METHODS: Fifteen inpatients...
Autores principales: | Sühs, Kurt-Wolfram, Correll, Christoph, Eberlein, Christian K, Pul, Refik, Frieling, Helge, Bleich, Stefan, Kahl, Kai G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356843/ https://www.ncbi.nlm.nih.gov/pubmed/25798333 http://dx.doi.org/10.1002/brb3.318 |
Ejemplares similares
-
Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018) -
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin
por: Sühs, Kurt-Wolfram, et al.
Publicado: (2016) -
Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients
por: PUL, REFIK, et al.
Publicado: (2016) -
Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies
por: Sühs, Kurt-Wolfram, et al.
Publicado: (2015) -
Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients
por: Maier, Hannah Benedictine, et al.
Publicado: (2022)